NTera 2 cells: A human cell line which displays characteristics expected of a human committed neuronal progenitor cell

Author(s): Pleasure SJ, Lee VM


We have identified a human cell line with a phenotype resembling committed CNS neuronal precursor cells. NTera 2/cl.D1 (NT2/D1) cells expressed nestin and vimentin, intermediate filament (IF) proteins expressed in neuroepithelial precursor cells, as well as MAP1b, a microtubule-associated protein (MAP) expressed in human neuroepithelium. NT2/D1 cells also expressed the cell adhesion molecules NCAM and N-cadherin which are thought to be important in cellcell interactions within the neuroepithelium. These NT2/D1 cells also expressed small amounts of NF-L, α-internexin, NF-M, and MAP2c, indicating that they are committed to a neuronal fate. Previous studies have shown that, following RA treatment, a proportion of NT2/D1 cells terminally differentiate into neurons and that this occurs via an asymmetric stem cell mode of differentiation. In light of the identification of the neuroepithelial phenotype of NT2/D1 cells we decided to examine more closely the relationship of in vitro neurogenesis in NT2/D1 cells, during RA treatment to that of neurons in vivo. Three days after RA treatment, islands of NT2/D1 cells showed increased expression of neurofilament proteins and increased phosphorylation of NF-M. By 10–14 days, these cells began to resemble neurons morphologically, i.e., with rounded cell bodies and processes. These neuronal cells were clustered into clumps which rested on top of a layer of progenitor cells. In this upper layer, the neurons began to express MAP2b and tau and extinguished their expression of mestin. Recently, we developed a method for obtaining pure cultures of neurons from RA treated NT2/D1 cells. The phenotype of these postmitotic neurons is clearly dissociated from that of the untreated NT2/D1 cells. Given the data obtained in this study and the characterization of the neurons derived from NT2/D1 cells, we propose that NT2/D1 cells are a committed human neuronal precursor cell line which retains some stem cell characteristics and is capable only of terminal differentiation into neurons.

Similar Articles

Developmental neurotoxicity of industrial chemicals

Author(s): Grandjean P, Landrigan PJ

Neurobehavioural effects of developmental toxicity

Author(s): Grandjean P, Landrigan PJ

A tiered approach to systemic toxicity testing for agricultural chemical safety assessment

Author(s): Doe JE, Boobis AR, Blacker A, Dellarco V, Doerrer NG, et al.

Human in vitro reporter model of neuronal development and early differentiation processes

Author(s): Couillard-Despres S, Quehl E, Altendorfer K, Bentley K, Brady AM, et al.

A human pluripotent stem cell platform for assessing developmental neural toxicity screening

Author(s): Hou Z, Zhang J, Schwartz MP, Stewart R, Page CD, et al.

Towards in vitro DT/DNT testing: Assaying chemical susceptibility in early differentiating NT2 cells

Author(s): Menzner AK, AbolpourMofrad S, Friedrich O, Gilbert DF

Neuropharmacological properties of neurons derived from human stem cells

Author(s): Coyne L, Shan M, Przyborski SA, Hirakawa R, Halliwell RF

Optimizing neuronal differentiation of human pluripotent NT2 stem cells in monolayer cultures

Author(s): AbolpourMofrad S, Kuenzel K, Friedrich O, Gilbert DF